Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 219 publications
BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians.
Journal: Advances in therapy
Published: June 01, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.
Journal: American journal of hematology
Published: May 12, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.
Journal: American journal of hematology
Published: March 31, 2026
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients.
Journal: American journal of hematology
Published: March 30, 2026
An evaluation of axatilimab for the treatment of chronic graft-versus-host disease.
Journal: Expert opinion on biological therapy
Published: March 19, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: January 14, 2026
Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers.
Journal: Blood cancer journal
Published: December 23, 2025
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone.
Journal: Haematologica
Published: December 21, 2025
Last Updated: 09/26/2026